GThepharmaceuticalmarketcanbedividedintodifferenttherapeuticsegmentsonthebasisofapplication.Therelativesharesofthevarioustherapeuticsegmentsdepend,toagreatextent,onthelevelofeconomicdevelopment,diseaseincidenceandtheavailabilityofhealthcareinfrastructureinacountry.InIndia,anti-infectivesaccountforthelargestmarketshareofabout26%.GThemarketforpharmaceuticalproductsisbroadlydividedintotheethicalsegment(drugsinthissegmentareavailableonlyagainstadoctor’sprescription)andtheover-the-counter(OTC)segment(nodoctor’sprescriptionisrequired).GAnti-diabetics,centralnervoussystem,andcardiovasculararethefastestgrowingsub-segmentsinthelifestyle-relatedsegmentoftheIndianpharmaceuticalmarket.GTheanti-infectivessegment,whichisthelargest,consistsoffivesub-segments:antibiotics;anti-protozoals;anti-helmintics;anti-malarials;andanti-tuberculosis.Theanti-infectivessegmentisestimatedtobegrowingattherateof2-3%perannum.GTherespiratorysegmentisthelargesttherapeuticsegmentintheOTCmarket.6ChapterHIGHLIGHTSTHERAPEUTICSEGMENTSTHEINDIANPHARMACEUTICALINDUSTRYPage87PRODUCTANDTECHNOLOGYPRODUCTANDTECHNOLOGYPRODUCTANDTECHNOLOGYPRODUCTANDTECHNOLOGYPRODUCTANDTECHNOLOGYTHERAPEUTICSEGMENTSMARKETSEGMENTATIONIntermsofend-use,thepharmaceuticalindustryissub-dividedintoseveraltherapeuticsegments.Thesesegmentsarebroadlydefinedonthebasisoftherapeuticapplication.Thevariousbroadtherapeuticsegmentsandthesub-segmentsundereachcategoryareasfollows:Box6.1TherapeuticSegmentsoftheIndianPharmaceuticalMarketNote:Becauseofmultipleapplications,someofthetherapeuticsegmentsareoverlappingCompiledbyICRAInformationServicesSomeofthesesegmentsarelow-volume,high-marginsegments,whiletheothersarehigh-volumewithrelativelylowmargins.Thegrowthtrendsacrossthetherapeuticsegmentsvarywidely.Whilethegrowthrateforlifestylerelateddrugs(suchascardiovascularandanti-diabetesdrugs)andthenew-generationantibiotics(suchasthelatest-generationcephalosporins)ishigh,thegrowthrateforolderanti-infectives(suchaspenicillinandampicillin,amongothers)hasdeclinedinrecenttimes.ThesharesofthedifferenttherapeuticsegmentsintheIndianretailmarketarepresentedinthefollowingchart.TherapeuticSegmentSub-Segments1.Anti-InfectiveAntibiotics(penicillin,sulphonamides,aminoglycosides,tetracyclines,macrolides,cephalosporins,quinolones,etc.),anti-parasitics(anti-protozoa,anti-malarials,anti-fungals,anti-helmintic,etc.),anti-tuberculosis,vaccines2.PainManagementAnti-pyretics&analgesics,nonsteroidalanti-inflammatorydrugs(NSAIDs),anti-arthritis3.Cardiovascular(CVS)Cardiactherapy,anti-hypertensivesandanti-hypotensives4.CentralNervousSystem(CNS)Analgesics,anti-psycotics,anti-epilepsy,tranquilisersandsedatives,anti-parkinson’sdisease5.DermatologicalPreparationsTopicalcorticosteriods,antisepticsandanti-fungals6.Gastro-IntestinalAlimentary,antacids,anti-ulcerants,anti-helmintics,anti-flatulents,anti-spasmodics,laxatives,digestiveenzymes7.Genito-UrinarySystemiccorticosteroids,sexhormones&stimulantsandgynaecological8.RespiratoryCoughandcoldpreparations,anti-asthmatics,anti-histamines9.Anti-DiabetesInsulin(animal,human),oralanti-diabetics10.OthersGeneralnutrients,minerals,vitamins,anti-anaemicpreparations,plasmaresearch,etc.ICRAINDUSTRYWATCHSERIESPage88THERAPEUTICSEGMENTSChart6.1Break-upofDomesticRetailFormulationsMarket(asofCalendar2001)MarketSize:Rs.154billionNote:Themarketsizesdepictedfollowa...
